REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Security
BIOLIDICS LIMITED - SGXE89830751 - 8YY

Announcement Details

Announcement Title
Outcome of Regulatory Review
Date &Time of Broadcast
30-Aug-2022 17:54:04
Status
Replacement
Corporate Action Reference
SG220812RHDI23LI
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Event Status
Pending AIP/ LQN Announcement
Underwritten
No
Shareholders' Approval Required?
No
Shareholders' Approval Obtained
No
Financial Year End
31/12/2022
Foreign Shareholder Eligibility
No
Attachment for Intent
Announcement of Rights Issue.pdf

Regulatory Outcome

Attachment For Regulatory Outcome
Receipt of LQN.pdf

Event Narrative

Narrative Type
Narrative Text
Additional TextPROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE

Please refer to the attachment.

Dates

Rights Details

Rights Security ISIN
SGXE89830751
Rights Security Name
BIOLIDICS LIMITED
Security Not Found?
No
Renounceable
Yes
Rights Security Distribution Ratio- Underlying
1
Rights Security Distribution Ratio- Rights Security
1

Option Exercise

Issue Price (Per Rights)
SGD 0.035
Disbursed Security
ISIN
Name
Security Type
Distribution Ratio- Rights
Distribution Ratio- Disbursed
SGXE89830751BIOLIDICS LIMITEDOrdinary Share11

Renounceable Conditions

Allow Over Subscription
Yes

Attachments

Announcement of Rights Issue.pdf
Receipt of LQN.pdf
Total size =265K

Related Announcements

Related Announcements

29/09/2022 21:27:43
12/08/2022 19:40:54